Norio Asou

Saitama, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 74 publications

Activation of NOTCH signaling impedes cell proliferation and survival in acute megakaryoblastic leukemia.

Activation of NOTCH signaling impedes cell proliferation and survival in acute megakaryoblastic leukemia.

Journal: Experimental hematology

Published: May 06, 2024

Nilotinib vs dasatinib in achieving MR4.5 for de novo chronic myeloid leukemia: the randomized JALSG CML212 study.

Nilotinib vs dasatinib in achieving MR4.5 for de novo chronic myeloid leukemia: the randomized JALSG CML212 study.

Journal: Blood advances

Published: January 15, 2024

Real-world data of MDS and CMML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11).

Real-world data of MDS and CMML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11).

Journal: International journal of hematology

Published: August 26, 2023

Real-world data of AML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11).

Real-world data of AML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11).

Journal: International journal of hematology

Published: June 25, 2023

Thoracic SMARCA4-deficient undifferentiated tumor resembling malignant lymphoma

Thoracic SMARCA4-deficient undifferentiated tumor resembling malignant lymphoma

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: April 30, 2023

Management and Risk Factors for Pleural Effusion in Japanese Patients with Chronic Myeloid Leukemia Treated with First-line Dasatinib in Real-world Clinical Practice.

Management and Risk Factors for Pleural Effusion in Japanese Patients with Chronic Myeloid Leukemia Treated with First-line Dasatinib in Real-world Clinical Practice.

Journal: Internal medicine (Tokyo, Japan)

Published: April 02, 2023

Outcomes of adolescents and young adults with chronic-phase chronic myeloid leukaemia treated with tyrosine kinase inhibitors.

Outcomes of adolescents and young adults with chronic-phase chronic myeloid leukaemia treated with tyrosine kinase inhibitors.

Journal: Annals of medicine

Published: April 29, 2022

Bendamustine-induced rash is associated with a favorable prognosis in patients with indolent B-cell lymphoma.

Bendamustine-induced rash is associated with a favorable prognosis in patients with indolent B-cell lymphoma.

Journal: Journal of clinical and experimental hematopathology : JCEH

Published: January 04, 2022

Paravertebral extramedullary hematopoiesis in a case of myelodysplastic syndrome with ring sideroblasts and an SF3B1 mutation.

Paravertebral extramedullary hematopoiesis in a case of myelodysplastic syndrome with ring sideroblasts and an SF3B1 mutation.

Journal: International journal of hematology

Published: October 31, 2021

Venetoclax plus azacitidine in Japanese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy.

Venetoclax plus azacitidine in Japanese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy.

Journal: Japanese journal of clinical oncology

Published: August 11, 2021

Venetoclax plus low-dose cytarabine in Japanese patients with untreated acute myeloid leukaemia ineligible for intensive chemotherapy.

Venetoclax plus low-dose cytarabine in Japanese patients with untreated acute myeloid leukaemia ineligible for intensive chemotherapy.

Journal: Japanese journal of clinical oncology

Published: May 13, 2021

Two novel high-risk adult B-cell acute lymphoblastic leukemia subtypes with high expression of CDX2 and IDH1/2 mutations.

Two novel high-risk adult B-cell acute lymphoblastic leukemia subtypes with high expression of CDX2 and IDH1/2 mutations.

Journal: Blood

Published: April 23, 2021

Showing 1-12 of 74

Last Updated: 09/26/2026